PanGenomic Health, Inc. Class A

As of June 30, 2026, PanGenomic Health, Inc. Class A has 25.70M shares outstanding.

As of June 30, 2026, PanGenomic Health, Inc. Class A maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -25.97, indicating conservative leverage, while an interest coverage ratio of -196.07 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -4,309.33, reflecting losses generated across the asset base.

As of the close on August 25, 2026, PanGenomic Health, Inc. Class A's stock has declined approximately 82.50% over the past 52 weeks. The 50-day moving average sits at 1.84, while the 200-day moving average is 1.86.

Over the twelve months ended June 30, 2026, PanGenomic Health, Inc. Class A generated - - in revenue and converted that into -4.25M in net income, yielding earnings per share of -0.18. EBITDA reached -4.19M, while operating income came in at -4.04M.

As of June 30, 2026, PanGenomic Health, Inc. Class A holds 7,717.00 in cash and equivalents against 715,335.00 in total debt, resulting in a net debt position of 707,618.00. Total book value stands at -2.75M, with working capital of -2.76M providing operational flexibility.

PanGenomic Health, Inc. Class A produced -2.21M in operating cash flow over the twelve months ended June 30, 2026.

PanGenomic Health, Inc. Class A's most recent stock split took place on November 28, 2024 with a 5:1 split ratio.